Enovis Quick Ratio 2012-2026 | ENOV
Historical quick ratio values for Enovis (ENOV) over the last 10 years.
| Enovis Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2026-03-31 | $0.64B | $0.61B | 1.05 |
| 2025-12-31 | $0.62B | $0.60B | 1.04 |
| 2025-09-30 | $0.67B | $0.58B | 1.16 |
| 2025-06-30 | $0.65B | $0.57B | 1.15 |
| 2025-03-31 | $0.63B | $0.48B | 1.32 |
| 2024-12-31 | $0.60B | $0.53B | 1.13 |
| 2024-09-30 | $0.59B | $0.53B | 1.12 |
| 2024-06-30 | $0.56B | $0.52B | 1.08 |
| 2024-03-31 | $0.57B | $0.55B | 1.03 |
| 2023-12-31 | $0.43B | $0.37B | 1.16 |
| 2023-09-30 | $0.38B | $0.36B | 1.08 |
| 2023-06-30 | $0.43B | $0.35B | 1.23 |
| 2023-03-31 | $0.39B | $0.35B | 1.13 |
| 2022-12-31 | $0.37B | $0.57B | 0.65 |
| 2022-09-30 | $0.59B | $0.85B | 0.69 |
| 2022-06-30 | $0.68B | $0.81B | 0.83 |
| 2022-03-31 | $1.50B | $1.45B | 1.03 |
| 2021-12-31 | $1.95B | $1.02B | 1.90 |
| 2021-09-30 | $0.95B | $0.98B | 0.97 |
| 2021-06-30 | $0.82B | $0.90B | 0.91 |
| 2021-03-31 | $1.47B | $1.56B | 0.94 |
| 2020-12-31 | $0.80B | $0.81B | 0.98 |
| 2020-09-30 | $0.75B | $0.79B | 0.96 |
| 2020-06-30 | $0.67B | $0.76B | 0.89 |
| 2020-03-31 | $1.02B | $0.82B | 1.25 |
| 2019-12-31 | $0.83B | $0.86B | 0.97 |
| 2019-09-30 | $2.92B | $1.51B | 1.94 |
| 2019-06-30 | $3.04B | $1.60B | 1.90 |
| 2019-03-31 | $1.67B | $1.57B | 1.06 |
| 2018-12-31 | $1.60B | $1.20B | 1.33 |
| 2018-09-30 | $1.47B | $1.07B | 1.37 |
| 2018-06-30 | $1.46B | $1.08B | 1.36 |
| 2018-03-31 | $1.66B | $1.10B | 1.52 |
| 2017-12-31 | $1.64B | $1.10B | 1.50 |
| 2017-09-30 | $1.90B | $1.29B | 1.48 |
| 2017-06-30 | $1.50B | $1.15B | 1.31 |
| 2017-03-31 | $1.35B | $1.08B | 1.25 |
| 2016-12-31 | $1.37B | $1.06B | 1.30 |
| 2016-09-30 | $1.38B | $1.08B | 1.28 |
| 2016-06-30 | $1.36B | $1.09B | 1.25 |
| 2016-03-31 | $1.33B | $1.10B | 1.21 |
| 2015-12-31 | $1.31B | $1.12B | 1.17 |
| 2015-09-30 | $1.55B | $1.21B | 1.29 |
| 2015-06-30 | $1.56B | $1.20B | 1.30 |
| 2015-03-31 | $1.57B | $1.26B | 1.25 |
| 2014-12-31 | $1.63B | $1.28B | 1.28 |
| 2014-09-30 | $1.70B | $1.37B | 1.24 |
| 2014-06-30 | $1.84B | $1.42B | 1.30 |
| 2014-03-31 | $1.87B | $1.31B | 1.42 |
| 2013-12-31 | $1.69B | $1.38B | 1.22 |
| 2013-09-30 | $1.91B | $1.32B | 1.45 |
| 2013-06-30 | $1.82B | $1.25B | 1.46 |
| 2013-03-31 | $1.48B | $1.27B | 1.17 |
| 2012-12-31 | $1.64B | $1.18B | 1.39 |
| 2012-09-30 | $1.71B | $1.22B | 1.40 |
| 2012-06-30 | $1.77B | $1.24B | 1.43 |
| 2012-03-31 | $1.78B | $1.20B | 1.49 |
| 2011-12-31 | $0.30B | $0.24B | 1.23 |
| 2011-09-30 | $0.27B | $0.21B | 1.25 |
| 2011-06-30 | $0.26B | $0.21B | 1.29 |
| 2011-03-31 | $0.26B | $0.21B | 1.24 |
| 2010-12-31 | $0.26B | $0.19B | 1.37 |
| 2010-09-30 | $0.23B | $0.17B | 1.36 |
| 2010-06-30 | $0.22B | $0.14B | 1.56 |
| 2010-03-31 | $0.22B | $0.15B | 1.49 |
| 2009-12-31 | $0.23B | $0.15B | 1.50 |
| 2009-09-30 | $0.23B | $0.16B | 1.49 |
| 2009-06-30 | $0.21B | $0.14B | 1.49 |
| 2009-03-31 | $0.20B | $0.14B | 1.45 |
| 2008-12-31 | $0.22B | $0.15B | 1.39 |
| 2008-09-30 | $0.23B | $0.17B | 1.39 |
| 2008-06-30 | $0.22B | $0.16B | 1.38 |
| 2008-03-31 | $0.21B | $0.19B | 1.13 |
| 2007-12-31 | $0.22B | $0.15B | 1.48 |
| 2007-09-30 | $0.00B | 0.00 | |
| 2007-06-30 | $0.00B | 0.00 | |
| 2007-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.405B | $2.248B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |